ACUVUE® Abiliti® 1-Day
Why manage myopia with Abiliti® 1-Day?
Proven efficacy
Shown to slow axial elongation by 0.25mm, on average, over a 2-year period*2
First & only§§
Daily disposable silicone hydrogel soft contact lenses specifically designed for slowing the progression of myopia in children1
Breakthrough
Breakthrough RingBoost™ technology with a specialised optical design1
Never beaten in comfort§
Abiliti® 1-Day is made from the same material as ACUVUE® OASYS 1-Day. In 7 clinical studies posted on ClinicalTrials.gov, the ACUVUE® OASYS daily disposable contact lens families have never been beaten in comfort§
How can your patients benefit from Abiliti® 1-Day?
Easy to handle
More than 90% of children indicated it was easy to apply after 1 month of wear^3
Lets kids be kids
Freedom from glasses during the day so your patients can lead an active lifestyle
Class 1 UV
Protection helps protect eyes from UV‡5
Clear vision
More than 95% of children achieved VA of 6/6 or better†3
Designed for children
With a smaller diameter and steeper base curve than a typical contact lens design‡‡4
"If I were to look at all of the patients that I have seen with Abiliti® 1-Day for the last year and a half, axial length changes have been minimal, and refractive error changes have almost been nothing. That’s very promising in my opinion"
-Dr. Vishakha Thakrar, OD, FAAO, FSLS#
An innovation to slow myopia progression in children1
Abiliti® 1-Day Lens Parameters Available
| Title | Description |
|---|---|
SKU Range | -0.25 to -8.00 D, 0.25 D steps (32 levels) |
Diameter | 13.8 mm |
Base Curve | 7.9 mm |
Modulus | 0.68 MPa¶6 |
Material | Senofilcon A |
UV Protection‡5 | Class 1 UV Blocking of 99.9% of UVB and 96% of UVA rays |
Central Thickness | 0.085 mm to 0.097 mm (varies with power) |
Dk/t (edge-corrected) | 121 x 10-9 |
Footnotes
*Compared to a single vision contact lens, from 2-year outcome of a pivotal clinical trial.
§ClinicalTrials.gov is a website maintained by the NIH. The 7 clinical studies evaluated subjective comfort as a primary or secondary endpoint for ACUVUE® OASYS 1-DAY Brand family contact lenses and ACUVUE® OASYS MAX 1-DAY Brand family vs. competitors’ products. Review conducted as of April 30, 2026.
‡All ACUVUE® Contact Lenses have Class 1 or Class 2 UV-blocking to help provide protection against transmission of harmful UV radiation to the cornea and into the eye. UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. You should continue to use UV absorbing eyewear as directed by your optician.
^JJV Data on File, 2021 Top 3 Box = Extremely easy, very easy, easy.
†Measured using LogMAR visual acuity where 0.00 LogMAR is equivalent to 20/20 vision.
‡‡Compared to the diameter and base curve of ACUVUE® OASYS 1-day lenses.
# Dr. Thakrar is a paid consultant for Johnson & Johnson Vision. This statement is from her own experience in her own words. Success results may vary.
§§Based on publicly available information as of December 3, 2021.¶MPa values calculated from psi measured values.
References
- JJV Data on file, 2021. Development of Optical Design of ACUVUE® Abiliti® 1-Day Soft Therapeutic Lenses for Myopia Management.
- JJV Data on file, 2021. Efficacy of ACUVUE® Abiliti® 1-Day Soft Therapeutic Lenses for Myopia Management: Comparative Claims vs. Single Vision and Dual Focus Lenses.
- JJV Data on file 2021. Stand-alone Performance Claims; ACUVUE® Abiliti® 1-Day Soft Therapeutic Lenses for Myopia Management.
- JJV Data on File 2021. Mechanical Design of ACUVUE® Abiliti® 1-Day Soft Therapeutic Lenses for Myopia Management - Effect on Fit and Handling.
- JJV Data on File 2021. Material Properties: ACUVUE® Abiliti® 1-Day Soft Therapeutic Lenses for Myopia Management.
- Sulley A, Mundorf M, & Arnold K. Reusable and Daily Disposable Contact Lens Moduli - Are They Really Different? Optom. Vis. Sci. 2018;41(S1):S54. doi: 10.1016/j.clae.2018.03.037.
Important safety information:
ACUVUE® Abiliti® 1-Day Soft Therapeutic Lenses for Myopia Management are indicated for the correction of myopia (while the lenses are worn) and may slow the progression of myopia in children (7-12 years old). As with any contact lenses, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. These contact lenses should not be used in case of eye infections or any other eye conditions, or in case of a systemic disease that may affect the eye. Due to the intended optical design of these lenses for the purpose of reducing the patient’s prescription change, these lenses will provide vision correction while worn, but the vision quality may not be as clear as with conventional soft contact lenses. Patients should exercise extra care if performing potentially hazardous, vision demanding activities. For detailed product information, including contraindications, precautions and adverse reactions, please consult the Instructions for Use available at www.e-ifu.com.
ACUVUE®, ACUVUE® Abiliti® 1-Day and RingBoost™ are registered trademarks of Johnson & Johnson.
Third-party trademarks used herein are trademarks of their respective owners.
© Johnson & Johnson and its affiliates 2026.
